The treatments generally employed for temporomandibular joint osteoarthritis (TMJOA) involve physical therapy and chemotherapy, etc., whose therapeutic efficacies are impaired by the side effects and suboptimal stimulus responsiveness. Although the intra-articular drug delivery system (DDS) has shown effectiveness in addressing osteoarthritis, there is currently little reported research regarding the use of stimuli-responsive DDS in managing TMJOA. Herein, we prepared a novel near-infrared (NIR) light-sensitive DDS (DS-TD/MPDA) by using mesoporous polydopamine nanospheres (MPDA) as NIR responders and drug carriers; diclofenac sodium (DS) as the anti-inflammatory medication; and 1-tetradecanol (TD) with a phase-inversion temperature of 39 °C as the drug administrator. Upon exposure to 808 nm NIR laser, DS-TD/MPDA could raise the temperature up to the melting point of TD through photothermal conversion, and intelligently trigger DS release. The resultant nanospheres exhibited an excellent photothermal effect and effectively controlled the release of DS through laser irradiation to accommodate the multifunctional therapeutic effect. More importantly, the biological evaluation of DS-TD/MPDA for TMJOA treatment was also performed for the first time. The experiments’ results demonstrated that DS-TD/MPDA displayed a good biocompatibility in vitro and in vivo during metabolism. After injection into the TMJ of rats afflicted with TMJOA induced by unilateral anterior crossbite for 14 days, DS-TD/MPDA could alleviate the deterioration of TMJ cartilage, thus ameliorating osteoarthritis. Therefore, DS-TD/MPDA could be a promising candidate for photothermal-chemotherapy for TMJOA.

An important task in facilitating the development of thermally conducting graphene/polymer nanocomposites is to suppress the intrinsically strong intersheet π-π stacking of graphene, and thereby to improve the exfoliation and dispersion of graphene in the matrix. Here, a pre-programmed intercalation approach to realize the in situ growth of graphene nanosheets at the inorganic template is demonstrated. Specifically, microsized MgO granules with controlled geometrical size were synthesized using a precipitation method, allowing the simultaneous realization of high surface activity. In the presence of a carbon and nitrogen source, the MgO granules were ready to induce the formation of graphene nanosheets (G@MgO), which allowed for the creation of tenacious linkages between graphene and template. More importantly, the incorporation of G@MgO into polymer composites largely pushed up the thermal conductivity, climbing from 0.39 W/m∙K for pristine polyethylene to 8.64 W/m∙K for polyethylene/G@MgO (60/40). This was accompanied by the simultaneous promotion of mechanical properties (tensile strength of around 30 MPa until 40 wt % addition of G@MgO), in contrast to the noteworthy decline of tensile strength for MgO-filled composites with over 20 wt.% fillers.

Guided bone regeneration (GBR) membrane has proven to be a fundamental tool in the realm of bone defect repair. In this study, we develop a mussel-inspired composite biomaterial through polydopamine-assisted, combining gelatin–WPU matrix with the ion-release behavior of Cu–MSNs for augmented bone regeneration. The optimized composite membrane exhibits enhanced mechanical stability, demonstrating a tensile strength of 11.23 MPa (representing a 2.3-fold increase compared to Bio-Gide^®), coupled with significantly slower degradation kinetics that retained 73.3% structural integrity after 35-day immersion in physiological solution. Copper ions act as angiogenic agents to promote blood vessel growth and as antimicrobial agents to prevent potential infections. The combined effect of these components creates a biomimetic environment that is ideal for cell adhesion, growth, and differentiation. This research significantly contributes to the development of advanced biomaterials that combine regeneration and infection-prevention functions. It provides a versatile and effective solution for treating bone injuries and defects, offering new hope for patients in need.